SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-071643
Filing Date
2022-11-14
Accepted
2022-11-14 08:35:42
Documents
54
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_adialpharm.htm   iXBRL 10-Q 633380
2 CERTIFICATION f10q0922ex31-1_adialpharm.htm EX-31.1 10962
3 CERTIFICATION f10q0922ex31-2_adialpharm.htm EX-31.2 11011
4 CERTIFICATION f10q0922ex32-1_adialpharm.htm EX-32.1 4444
5 CERTIFICATION f10q0922ex32-2_adialpharm.htm EX-32.2 4286
  Complete submission text file 0001213900-22-071643.txt   3554909

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20220930.xsd EX-101.SCH 48678
7 XBRL CALCULATION FILE adil-20220930_cal.xml EX-101.CAL 28110
8 XBRL DEFINITION FILE adil-20220930_def.xml EX-101.DEF 169589
9 XBRL LABEL FILE adil-20220930_lab.xml EX-101.LAB 396241
10 XBRL PRESENTATION FILE adil-20220930_pre.xml EX-101.PRE 185879
48 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_adialpharm_htm.xml XML 349780
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 221380646
SIC: 2834 Pharmaceutical Preparations